New nonimmunological method of measuring fibrinogen-fibrin degradation products.

[1]  J. Soria,et al.  Determination of fibrinogen degradation products using antifibrinogen serum and anti-fragment E serum , 1973 .

[2]  J. Cash,et al.  Studies on a direct latex agglutination technique for the semiquantitation of fibrin/fibrinogen degradation products , 1973 .

[3]  E. Sack,et al.  Fibrinogen degradation products. , 1971, The New England journal of medicine.

[4]  C. Thuot,et al.  Fibrinogen degradation products: a critical study of two assay methods. , 1971, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

[5]  R. Colman,et al.  A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. , 1970, The New England journal of medicine.

[6]  D. Thomas,et al.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. , 1970, The Journal of laboratory and clinical medicine.

[7]  P. Lalezari,et al.  A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  V. Marder,et al.  High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. , 1969, The Journal of biological chemistry.

[9]  C. Merskey,et al.  The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis , 1967, British journal of haematology.

[10]  F. Rodríguez-Erdmann.  Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). , 1965, The New England journal of medicine.

[11]  A. Budzynski,et al.  Inhibition of Thrombin and of Fibrin Polymerization, Two Activities derived from Plasmin-digested Fibrinogen , 1964, Nature.

[12]  H. C. Ferreira,et al.  An Immunological Method for Demonstrating Fibrin Degradation Products in Serum and its Use in the Diagnosis of Fibrinolytic States , 1963, British journal of haematology.

[13]  A. Fletcher,et al.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. , 1962, The Journal of clinical investigation.

[14]  T. B. Bayles,et al.  The erythrocyte in rheumatoid arthritis. I. A method for the detection of an abnormal globulin coating. , 1961, The New England journal of medicine.

[15]  J. Hers,et al.  Chronic Antithrombinaemia (Antithrombin V) with Haemorrhagic Diathesis in a Case of Rheumatoid Arthritis with Hypergammaglobulinaemia , 1957, Thrombosis and Haemostasis.

[16]  J. Scheidegger.  Une micro-méthode de l’immuno-électrophorèse , 1955 .